Benzydamine

ALIMENTARY TRACT AND METABOLISM

Key facts

Benzydamine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including GUCY1B2|GUCY1A2|GUCY1A3|GUCY1B3. Recorded indications include Pain.

• Molecular targets: GUCY1B2|GUCY1A2|GUCY1A3|GUCY1B3 (1 listed in DrugCentral).
• Indications: Pain.
• ATC code: A01AD02 (Other agents for local oral treatment).
• Molecular formula: C19H23N3O; molecular weight 309.41 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Pain

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Soluble guanylate cyclase	GUCY1B2|GUCY1A2|GUCY1A3|GUCY1B3	unknown	EC50 5.99

ATC classification

ATC code	Therapeutic hierarchy
A01AD02	ALIMENTARY TRACT AND METABOLISM › STOMATOLOGICAL PREPARATIONS › STOMATOLOGICAL PREPARATIONS › Other agents for local oral treatment
G02CC03	GENITO URINARY SYSTEM AND SEX HORMONES › OTHER GYNECOLOGICALS › OTHER GYNECOLOGICALS › Antiinflammatory products for vaginal administration
M01AX07	MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Other antiinflammatory and antirheumatic agents, non-steroids
M02AA05	MUSCULO-SKELETAL SYSTEM › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › Antiinflammatory preparations, non-steroids for topical use
R02AX03	RESPIRATORY SYSTEM › THROAT PREPARATIONS › THROAT PREPARATIONS › Other throat preparations

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Macular degeneration	483.6
Vaginal flatulence	457.8
Female genital tract fistula	422.1
Proctitis	411.2
Vaginal discharge	407.3
Chronic sinusitis	403.1
Radiculopathy	394.5
Paraesthesia oral	371.0
Oral candidiasis	318.4
Procedural pain	295.3
Frequent bowel movements	257.1
Rectal haemorrhage	251.0

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Benzydamine is on its molecule page.

• Molecular formula: C₁₉H₂₃N₃O
• Molecular weight: 309.41 g/mol
• CAS number: 642-72-8
• InChIKey: CNBGNNVCVSKAQZ-UHFFFAOYSA-N
• PubChem CID: 12555

CN(C)CCCOC1=NN(CC2=CC=CC=C2)C2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Benzydamine used for?

DrugCentral lists the following indications for Benzydamine: Pain.

How does Benzydamine work?

Its molecular targets in DrugCentral include GUCY1B2|GUCY1A2|GUCY1A3|GUCY1B3.

What is the chemical formula of Benzydamine?

Benzydamine has the molecular formula C19H23N3O and a molecular weight of 309.41 g/mol.

Sources

• DrugCentral drug card 3881 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL12610 — compound record and bioactivity
• PubChem CID 12555 — chemical identifiers
• DrugBank DB09084 — drug record
• FDA UNII 4O21U048EF — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.